2a Ascorbate IV Oxidant Data, Laboratory Measurement and Safety
Pharmacology, Kinetics, Dosing and Safety of Intravenous Ascorbic Acid
Prepared as Data for Safe use of Ascorbic Acid in Human Research
As performed at Anderson Medical Specialty Associates in support of the Bastyr University Integrative Oncology Outcomes
Updated Data Review and Policies for concurrent use at Anderson Medical Specialty Associates, Southwest College of Naturopathic Medicine Research Institute and Medical Center and Bastyr University Clinical Research Center
6B - Leukemia and Oxidative Therapies Including Intravenous Ascorbic Acid / HDIVC
A seeming conundrum regarding the ability of some leukemic cells (i.e. CLL) to sequester ascorbate (ASC) has led to confusion regarding the safety and utility of high dose ascorbate delivered via IV (HDIVC). This has led to some apparent confusion between this concern and the apparent positive benefits of HDIVC seen in clinical practice.
Use in cell repair and augmentation of parenteral glutathione before and after administration:
Rationale and formula developed for the BIORC – AMSA Clinics during the integrative oncology study.